欢迎您注册蒲公英
您需要 登录 才可以下载或查看，没有帐号？立即注册
x
Samsung BioLogics obtained ISO 22301 certificate
Samsung BioLogics, one of the global biologics development and manufacturing companies, announced that it received ISO 22301 certificate, the international standard Business Continuity Management System (BCMS)（商业可持续管理系统国际标准？？）, as the first Korean pharmaceutical company from BSI (British Standards Institution), a global certification association. ISO 22301 certificate is a comprehensive standard published by the International Organization for Standardization (ISO) that represents the highest level of commitment to business continuity and disaster preparedness. In the case of biopharmaceuticals, the production and supply of biologics is directly linked to the life of patients suffering from serious disease including cancer, so it is crucial to stably produce and recover from the crisis. Accordingly, global pharmaceutical companies consider crisis systems critical and request a high level of crisis response system from their partners. Samsung BioLogics has launched internal task force composed of 16 teams and 22 people and has discovered a total of 573 projected risks for about two years, reflecting global customer’ needs. Ultimately, Samsung BioLogics has established an emergency response scenario by anticipating the internal and external crisis that may happen in order to obtain ISO certification. Furthermore it has also proved that Samsung is able to maintain the continuity of management in a short period of time in case of unexpected emergency such as incident and disaster, by pre-setting and preparing the resources and time required to overcome the crisis.
SOURCE:SAMSUNG BIOLOGICS
| 
|手机版|蒲公英|ouryao|蒲公英
( 京ICP备14042168号-1 ) 增值电信业务经营许可证编号：京B2-20243455 互联网药品信息服务资格证书编号：(京)-非经营性-2024-0033
发表于 2018-5-1 17:33:02
置顶卡
变色卡
楼主
